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Gene deliveryAberrant activation of Wnt signaling contributes to ischemia-induced retinal neovascularization in
oxygen-induced retinopathy (OIR), although the underlying mechanism is so far unclear. Here, we
show that microRNA-184 (miR-184) is signiﬁcantly down-regulated in the retina of OIR mice, and
miR-184 negatively modulates Wnt signaling both in vivo and in vitro. Furthermore, we show that
the Wnt receptor, frizzled-7, is a downstream target of miR-184, and delivery of miR-184 mimic
inhibits Wnt signaling in the OIR retina. These results suggest that decreased levels of miR-184
are responsible, at least in part, for the aberrant activation of Wnt signaling in ischemia-induced
retinal neovascularization.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MicroRNAs (miRNAs) are single-stranded, small (19–24 nucleo-
tides) non-coding RNA molecules [1] and serve as negative reg-
ulators in gene expression at the posttranscriptional level by
partially complementary binding to the 30 un-translated region
(30UTR) of target mRNAs [2–8]. It is known that miRNAs are widely
present in the body and regulate a variety of developmental and
physiological processes [3]. Although it is reported that expressionchanges of some miRNAs are implicated in the development and
progression of various diseases including diabetes [9,10], the
pathogenic roles of miRNAs in diabetes and its complications
remain unclear.
Diabetic retinopathy (DR), one of the major complications of
diabetes, is the most common diabetic eye disease and a leading
cause of blindness among the working age population in the US
[11]. Accumulating evidence suggests that chronic inﬂammation
and oxidative stress in the retina play important pathogenic roles
in DR [12–14]. Oxygen-induced retinopathy (OIR) is a well-estab-
lished animal model of ischemia-induced retinal inﬂammation
and neovascularization (NV) which recapitulates pathologies of
proliferative diabetic retinopathy (PDR). Thus, OIR is commonly
used as a model of PDR [15].
Wnt signaling is a conserved intracellular signaling pathway
consisting of Wnt ligands, their co-receptors and an intracellular
signaling cascade and regulates multiple cellular processes, such
as cell differentiation, inﬂammation, carcinogenesis and angio-
genesis [16–19]. It has been reported that aberrant-activation of
the Wnt signaling in the retina is a major pathogenic mechanism
for retinal inﬂammation and NV in DR and in the OIR model
Table 1
Primer sequences in this study.
Primer name Primer sequence (50–30) Product size
Vegf-a Fwd GCCAGCACATAGAGAGAATGAGC 97
Vegf-a Rev CAAGGCTCACAGTGATTTTCTGG
Gfap Fwd ATCGAGATCGCCACCTACAG 150
Gfap Rev TACCACGATGTTCCTCTTGA
Hprt1 Fwd CAGGCCAGACTTTGTTGGAT 147
Hprt1 Rev TTGCGCTCATCTTAGGCTTT
Vegf-a, vascular endothelial growth factor-a [40]; Gfap, glial ﬁbrillary acidic protein;
Hprt1, hypoxanthine phosphoribosyltransferase 1 [28].
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is poorly understood.
It was reported that microRNA-184 (miR-184) is abundantly
expressed in the cornea and lens [23], and single-base substitution
in the miR-184 seed region is associated with corneal diseases and
cataract [24–26]. In addition, an earlier study reported that several
miRNAs including miR-184 are implicated in ocular NV in the OIR
model and the non-ischemia retinopathy (laser-induced choroidal
NV) model [27].
Here, we veriﬁed that miR-184 was down-regulated in the
retina of OIR mice and identiﬁed that miR-184 negatively modu-
lates canonical Wnt signaling through the regulation of expression
of the Wnt receptor frizzled-7 (Fzd7).2. Materials and methods
2.1. Animals
C57BL/6J and Axin2LacZ mice [28] were purchased from Jackson
Laboratories (Bar Harbor, ME) and maintained in 12 h light and
12 h dark cycles. The Axin2 gene is a known target gene of canoni-
cal Wnt signaling, and Axin2LacZ mice were generated via in-frame
insertion of a nuclear-localized b-galactosidase (NLS-LacZ) to
visualize the locations of Wnt signal activation [28,29]. All of the
experiments involving mice were approved by the Institutional
Animal Care and Use Committees (IACUC) at the University of
Oklahoma Health Sciences Center, and performed following the
guidelines of the Association for Research in Vision and
Ophthalmology (ARVO) statement for the ‘‘Use of Animals in
Ophthalmic and Vision Research’’.
2.2. Oxygen-induced retinopathy (OIR) model
C57BL/6J or Axin2LacZmice were exposed to 75% O2 from postna-
tal day 7 (P7) to P12. Age-matched mice with the same genetic
background were maintained in constant room air (normoxia con-
trol) as the negative control. The retinas were isolated at P16 for
RNA or protein analyses.
2.3. Quantitative real-time RT-PCR (qRT-PCR) for microRNA and mRNA
expression analyses
RNA extraction and qRT-PCR for miRNA (TaqMan miRNA assay,
Lifetech, Carlsbad, CA: miR-184, U6-snRNA) and mRNAs (Vegf-a,
Gfap, Hprt1: primer sequences were shown in Table 1) were per-
formed as described previously [30].
2.4. Western blot analysis
Brieﬂy, equal amounts of total cellular proteins (20 lg) were
resolved on 10% SDS–PAGE gel and electro-transferred onto a
nitrocellulose membrane. Western blot analysis was conducted
as described previously [30]. Rabbit polyclonal antibodies for phos-
phorylated-LRP6 and non-phosphorylated-b-catenin were pur-
chased from Cell Signaling (Danvers, MA); a rabbit polyclonal
antibody for VEGF-A was purchased from Santa Cruz (Dallas, TX);
a mouse monoclonal antibody for b-actin was purchased from
Sigma–Aldrich (Saint Louis, IL) and an anti-Fzd7 mouse mono-
clonal antibody was purchased from LifeSpan Biosciences
(Seattle, WA).
2.5. In vivo and in vitro Wnt signaling activity assays
Wnt signaling activation in the retina of Wnt signaling reporter
(Axin2LacZ) mice was evaluated by the Wnt reporter gene,b-galactosidase activity assay using Senescence Cells Histo-
chemical staining kit (Sigma–Aldrich). A rat Müller cell line, rMC-
1 [31], with stably expressing a ﬁreﬂy luciferase controlled by
Wnt/b-catenin system, was generated by lentivirus infection and
antibiotic (puromycin, Sigma–Aldrich) resistance selection [32].
The equal amounts (12.5 pmol/0.5 mL (25 nM) each) of negative
control miRNA mimic or miR-184 mimic (Invitrogen, Carlsbad,
CA), and 2.5 pmol/0.5 mL (5 nM) of miR-184 mimic plus 25 pmol/
0.5 mL (50 nM) of negative control miRNA inhibitor or miR-184
inhibitor (Invitrogen, Carlsbad, CA) using Lipofectamine
RNAiMAX (Invitrogen), and culture media were replaced at 6 h
post-transfection. The cells were treated with 10% Wnt3A-condi-
tioned media (W3A) at 32 h post-transfection, and a luciferase-
basedWnt signaling activity assay (TOP ﬂash assay) was conducted
at 48 h post-transfection following the manufacturer’s protocol
(Promega Corporation, Madison, WI).
2.6. Veriﬁcation of downstream target of miR-184
The downstream target of miR-184 was validated with lucifer-
ase-based assay as described previously [30]. Brieﬂy, approxi-
mately 700 base-pairs of the human Fzd7 30UTR was cloned into
the pmirGLO Dual-Luciferase miRNA Target Expression Vector
(Promega). In addition, a scrambled sequence of miR-184 was
cloned into the same vector as a negative control and a reverse
complemental sequence of miR-184 was cloned into the same vec-
tor as a positive control. Further, we generated a point-mutant and
a deletion mutant of the miR-184-binding site in Fzd7 30UTR to
verify the impact of the binding site of miR-184 on Fzd7 expres-
sion. For in vitro analysis, the equal amount of assay vectors
(0.2 lg each: scrambled, MIR-184, Fzd7-wt, Fzd7-Mut, and Fzd7-
Del) were separately transfected into 293A cells (Qbiogen,
Montreal, Canada) with 12.5 pmol/0.5 mL (25 nM) of either pre-
miRNA negative control or miR-184 mimic (Invitrogen) using
Lipofectamine2000 (Invitrogen). At 48 h post-transfection, dual-lu-
ciferase assay (Promega) was conducted following the manufac-
turer’s protocol.
2.7. Nanoparticle formulation and delivery into the eye
A pre-miRNA negative control and a miR-184 mimic (miRIDIAN
Mimic, Thermo Fisher Scientiﬁc, Chicago, IL) were separately
packed in liposome-based nanoparticles as described by Rajala
et al. [33]. One-lL of the prepared nanoparticle (approximately
5.5 pmol of pre-miRNA) was injected into the vitreous space of
OIR mice at P12, andWnt signaling activity in the retina was evalu-
ated with X-gal staining at P16.
2.8. Statistical analysis
All of quantitative data were expressed as Mean ± S.E.M. and
represented as fold of control. At least three individual measure-
ments were conducted and Student’s t-test in Microsoft Excel
Y. Takahashi et al. / FEBS Letters 589 (2015) 1143–1149 1145(Microsoft, Redmond, WA) was performed to determine the sta-
tistical signiﬁcance for comparison of two data sets. Signiﬁcance
was denoted as ⁄P < 0.05, ⁄⁄P < 0.01 and ⁄⁄⁄P < 0.001, respectively.
3. Results
3.1. Activation of canonical Wnt signaling in the retina of OIR mice
Firstly, we evaluated Wnt signaling activation in the retina of
OIR mice. The Axin2LacZ Wnt signal reporter mice [28,29] were
placed in the oxygen chamber (75% Oxygen) at P7 for 5 days (OIR
model). Wnt signaling activation was evaluated by X-gal staining
of retinal sections of normoxia control (Fig. 1A) and OIR (Fig. 1B)
Axin2LacZ mice at P16. Substantial blue color staining was observed
in the retina of OIR Axin2LacZ mice, but not in the normoxia control,
indicating Wnt signaling activation in the OIR retina. In addition,
Western blot analyses showed up-regulation of phosphorylated-**
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Fig. 1. Activation of canonical Wnt signaling in the retina of OIR mice. Wnt
signaling activation was evaluated by X-gal staining of retinal sections of normoxia
control (A) or OIR (B) Axin2Lacz mice at P16. Western blot analysis of phos-
phorylated-LRP6 (C and D) and non-phosphorylated-b-catenin (C and E) was
performed using the retinas from the OIR C57BL/6J mice and normoxia control. The
expression of Vegf-a (F), a major inﬂammatory factor, and Gfap (G), a commonly
used stress marker, at the mRNA level in the retina of OIR mice was analyzed by
qRT-PCR.LRP6 [34] (Fig. 1C and D) and non-phosphorylated-b-catenin [35]
in the retinas of OIR C57BL/6J mice (Fig. 1C and E), further verifying
activation of Wnt signaling in the OIR retina. Further, mRNA
expression of Vegf-a (Fig. 1F), a major angiogenic factor and target
gene of Wnt signaling, and Gfap (Fig. 1G), a commonly used stress
marker in the retina [36,37], were signiﬁcantly up-regulated in the
retina of OIR mice. These results suggested that canonical Wnt sig-
naling was activated in the retina of OIR mice, consistent with pre-
vious reports [20].
3.2. Expression level of miR-184 in the retina of OIR mice and Wnt
signaling modulation by miR-184
Following the OIR procedure, the retinas were isolated at P16
for RNA extraction. As shown by qRT-PCR, the level of miR-184
was signiﬁcantly down-regulated in the retina of OIR mice com-
pared to that in the normoxia control (Fig. 2A). Furthermore, an
rMC1-TOP cells were generated using rMC1 cells, a rat Müller cell
line [31], infected with lentivirus expressing luciferase reporter
gene under a promoter containing TCF/b-catenin-binding sites
[32] to evaluate Wnt signaling activity in retinal cells. The rMC1-
TOP cells were separately transfected with the negative control
miRNA, miR-184 mimic or miR-184 inhibitor. In vitro Wnt signal-
ing activation assay (TOP-Flash assay) was conducted at 48 h post-
transfection. Transfection of miR-184 mimic signiﬁcantly inhibited
Wnt signaling activity, whereas the miR-184 inhibitor signiﬁcantly
enhanced Wnt activity (Fig. 2B). It should be noted that the Wnt
signaling activity in the cells treated with W3A-conditioned media
increased approximately 5.2-fold over that of negative control L-
cell conditioned media (data not shown).(Mean±SEM, Normal; n=7, OIR; n=6, * p<0.05)
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Fig. 2. Expression of miR-184 in the retina of OIR mice and regulation of Wnt
signaling by miR-184. C57BL/6J mice were under room air (normoxia control) or in
the oxygen chamber from P7 to P12 (OIR model). Expression levels of miR-184 in
the retinas at P16 were evaluated by qRT-PCR (A). MiR-184 mimic and its control
(25 nM each) or miR-184 inhibitor and its control (50 nM each plus 5 nM miR-184
mimic) were separately transfected into rMC1-TOP cells stably expressing ﬁreﬂy
luciferase under the control of the Wnt/b-catenin system. The cells were treated
with W3A-conditioned medium (10%) at 32 h post-transfection and Wnt signaling
activity assay (TOP ﬂash assay) was conducted at 48 h post-transfection (B).
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Fig. 3. Veriﬁcation of downstream target of miR-184. Approximately 700 bps of the 30UTR of the Fzd7 cDNA including the predicted miR-184-binding site was subcloned into
pmirGLO vector (A; Fzd7 Wt). Further, the predicted binding site of miR-184 (seed region) in the Fzd7 30UTR was either mutated (A; Fzd7 Mut, 3 nucleotides in seed region
were substituted) or deleted (A; Fzd7 Del). Generated pmirGLO vector containing a scrambled sequence of miR-184 was used as a negative control (Scrambled) and reverse-
complementary sequence of miR-184 as a positive control (B; MIR-184). The 30UTR of Fzd7 Wt, Mut, and Del were co-transfected with negative control miRNA mimic (Nc,
black bar) or miR-184 mimic (miR-184, white bar). Predicted secondary structure and minimum free energy (mfe) of the miR-184-binding site in the Fzd7 30UTR were
represented (C). At 48 h post-transfection, luciferase assay was conducted (D). The retinas were collected from normoxia or OIR mice at P16, and Western blot analysis was
conducted to evaluate the retinal level of Fzd7 protein (E and F).
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Bioinformatics analysis predicted that the mRNA of frizzled-7
(Fzd7), which is a receptor of canonical Wnt signaling, contains a
binding site of miR-184 in the 30UTR (Fig. 3A and C). Therefore,
the Fzd7 cDNA 30UTR including the predicted binding site was sub-
cloned into the pmirGLO vector (Fzd7Wt) (Fig. 3A). The interaction
of miR-184 with this binding site in Fzd7 30UTR was evaluated
using luciferase-based assays. The miR-184 mimic transfection sig-
niﬁcantly down-regulated the expression of ﬁreﬂy luciferase in the
cells co-transfected with the positive control (MIR-184) and Wt
Fzd7 assay vectors, whereas no effect was observed in the negative
control miRNA transfection (Fig. 3D). It should be noted that other
predicted downstream target genes of miR-184 related to Wnt sig-
naling did not regulate the expression of ﬁreﬂy luciferase (Suppl.
Figs. 1 and 2). To further verify the miR-184-binding site in the
30UTR of the Fzd7 mRNA, we have mutated and deleted the pre-
dicted miR-184-binding site in the assay vectors. Luciferaseactivity assays showed that miR-184 failed to regulate the reporter
gene expression after the binding site was mutated (Fzd7 Mut) or
deleted (Fzd7 Del). These results suggest that Fzd7 is a downstream
target of miR-184. Furthermore, the protein level of Fzd7 in the
retina of OIR mice was evaluated by Western blot analysis, which
showed that Fzd7 protein was signiﬁcantly up-regulated in the
retina of OIR mice (Fig. 3E and F).
3.4. Regulation of Wnt signaling by miR-184 in the retina of OIR mice
To elucidate the functional role of miR-184 in vivo, the negative
control miRNA mimic and miR-184 mimic were separately packed
in nanoparticles and injected into the vitreous space of OIR mice at
P12. Its impact on Wnt signaling was examined at P16. A retinal
section of OIR Axin2Lacz mice injected with the negative control
nanoparticle showed intense X-gal staining (Fig. 4A) indicating
activation of Wnt signaling. This was consistent with the result
in the retinal section of OIR mice without miRNA injection as
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Fig. 4. Delivery of miR-184 into the retina of OIR mice and its impact on Wnt signaling. Wnt signaling activation was evaluated by X-gal staining of retinal sections on
negative control nanoparticle-injected (A, OIR + NP(Nc)) or miR-184 nanoparticle-injected (B, OIR + NP(miR-184)) OIR-Axin2 mice at P16. Western blot analyses of
phosphorylated-LRP6 (C and D) and non-phosphorylated-b-catenin (C and E) were performed using negative control or miR-184 nanoparticle-injected OIR retina at P16.
Further, expression of Fzd7 (C and F), a downstream target of miR-184, and Vegf-a (C and G), a target gene of Wnt signaling, in the retina of the miRNAs-injected OIR mice was
evaluated by Western blot analysis.
Y. Takahashi et al. / FEBS Letters 589 (2015) 1143–1149 1147shown in Fig. 1B. On the other hand, the retinal section of OIR mice
injected with miR-184 nanoparticles showed substantial reduction
of X-gal staining (Fig. 4B) compared to that injected with the
negative control miRNA (Fig. 4A), indicating that Wnt signaling
was attenuated by miR-184 delivery. In addition, Western blot
analyses showed signiﬁcant reductions of phosphorylated-LRP6
(Fig. 4C and D) and non-phosphorylated-b-catenin (Fig. 4C and E)
in the retina of OIR mice injected with miR-184, suggesting
attenuation of Wnt signaling. Furthermore, expression levels of
Fzd7, which is identiﬁed as a downstream target of miR-184 in this
study, and Vegf-a, a target gene of Wnt signaling, were reduced in
the retina of OIR mice with miR-184 injection (Fig. 4C and F).
4. Discussion
Our earlier studies suggested that Wnt signaling is activated in
the diabetic retina, which plays a major pathogenic role in retinal
inﬂammation and NV in DR [20,38,39]. However, the role of
miRNAs in the Wnt signaling regulation in DR is not well-under-
stood. In the present study, we identiﬁed the functional role of
miR-184 in ischemia-induced retinal inﬂammation and NV (oxy-
gen-induced retinopathy, OIR), a mouse model of PDR. We ﬁrstly
veriﬁed that Wnt signaling was activated (Fig. 1), while the expres-
sion of miR-184 was signiﬁcantly down-regulated in the retina of
OIR mice (Fig. 2A). These results were consistent with earlier stud-
ies [20,27,38,39].
Then, we generated a rat Müller cell line stably expressing a
Wnt signaling reporter gene, a ﬁreﬂy luciferase controlled by the
Wnt/b-catenin system (rMC1-TOP) to examine whether Wntsignaling in Müller cells is regulated by miR-184, since Wnt signal-
ing activation was predominantly observed in the cells in the inner
retina (Fig. 1A). Wnt signaling in the rMC1-TOP cells was signiﬁ-
cantly inhibited by transfection of the miR-184 mimic, while
enhanced by the miR-184 inhibitor (Fig. 2B). These results strongly
suggest that there is a link between the reduction of miR-184
expression and activation of Wnt signaling in the retina of OIR
mice.
Next, we investigated a new downstream target of miR-184
implicated in canonical Wnt signaling. Through the bioinformatics
analysis, mutagenesis of the predicted miR-184-binding site and
luciferase-based assays, for the ﬁrst time we identiﬁed that Fzd7
is a direct target gene of miR-184 among a number of candidate
target genes in Wnt signaling (Fig. 3 and Suppl. Figs. 1 and 2). In
addition, Western blot analysis showed that Fzd7 protein was
increased in the OIR mouse retina (Fig. 3E). This provides a further
support that Fzd7 is the target gene of miR-184. For comparison,
we also examined a luciferase assay vector containing another
putative binding site of miR-184 in the 30UTR of Fzd4 (accession
number NM_008055.4: nucleotide number, 3592–3612), and it
did not reduce the luciferase expression by miR-184 mimic trans-
fection (Suppl. Figs. 1 and 2). This result is consistent in-line with a
previous observation that Fzd4 protein was not reduced in the OIR
mouse retina by pre-miR-184 (miR-184 mimic) injection [27].
In addition to miR-184, other miRNAs (miR-1, 23b, 27a) were
recently identiﬁed as miRNAs regulating Fzd7 in stem cells and
cancer cells [40–42], suggesting that these miRNAs may modulate
Wnt signaling in the same fashion as miR-184. It was also reported
that Fzd7 is involved in both canonical and non-canonical Wnt
1148 Y. Takahashi et al. / FEBS Letters 589 (2015) 1143–1149signaling in cancer cells [43], and Wnt3A acts as a ligand of Fzd7 in
canonical Wnt signaling [44]. Moreover, it was suggested that Fzd7
is a target gene of canonical Wnt signaling, since there is a TCF/b-
catenin-binding site in the promoter region of the Fzd7 gene [45].
This suggests that Fzd7 may create a positive feedback loop in
canonical Wnt signaling, and down-regulation of Fzd7 expression
by miR-184 may be ascribed to the modulation of the canonical
Wnt signaling.
Interestingly, Dismuke et al. recently showed that miR-184
abundantly exists in exosomes of the intraocular ﬂuid [46]. As
described earlier, it was reported that the major sources of miR-
184 in the eye are the cornea and lens [23,47]. It is well-established
that exosomes containing unique miRNA species are implicated in
cell-to-cell communication [48,49]. This exosome-mediated deliv-
ery of miR-184 from the cornea and lens might be an additional
mechanism responsible for the elevated level of miR-184 in the
retina, in addition to up-regulation in retinal cells.
To further establish the causative role of miR-184 in Wnt sig-
naling activation in the retina, we showed that delivery of the
miR-184mimic formulated in nanoparticles substantially inhibited
Wnt signaling in the retina of OIR mice (Fig. 4B), compared to the
negative control nanoparticle (Fig. 4A). Although the present study
did not conduct the functional assays on inﬂammatory responses,
vascular leakage and neovascularization in the retina, our previous
studies have demonstrated that inhibition of Wnt signaling in the
OIR model ameliorates these pathogenic features [20,38,39].
Another recent study also showed that the level of miR-184 was
down-regulated in a mouse model of spinal cord of diabetic neuro-
pathic pain [50]. It was reported that Wnt signaling regulates neu-
roinﬂammation to promote chronic pain, and the miR-184
reduction-mediated activation of Wnt signaling causes the devel-
opment of neuropathic pain [51]. The present study may reveal
the therapeutic potential using miR-184 nanoparticles as a new
class of drugs for diseases associated with dysregulation of Wnt
signaling.
In summary, the present study for the ﬁrst time showed that
delivery (or over-expression) of miR-184 in the retina with ische-
mia-induced retinal NV inhibits Wnt signaling as well as vegf-a
(a major proinﬂammatory and angiogenic factor) expression. This
may offer a new therapeutic strategy to prevent the inﬂammatory
responses, vascular leakage and NV through canonical Wnt signal-
ing in DR.
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